EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

SARS-CoV-2 Specific Nanobodies Neutralize Different Variants of Concern and Reduce Virus Load in the Brain of h-ACE2 Transgenic Mice

María Florencia Pavan, Marina Bok iD, Rafael Betanzos San Juan iD, Juan Pablo Malito, Gisela Ariana Marcoppido, Diego Rafael Franco, Daniela Ayelen Militelo, Juan Manuel Schammas, Sara Elizabeth Bari, William Stone, Krisangel López, Danielle LaBrie Porier und 6 weitere

Viruses · 2024

DOI: 10.3390/v16020185 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Viruses, 2024. Verfasst von María Florencia Pavan und 17 weiteren Autor:innen. Beteiligte Einrichtung: Instituto de Química Física de los Materiales, Medio Ambiente y Energía (INQUIMAE), Universidad de Buenos Aires, Consejo Nacional de Investigaciones …. Hauptthemen laut MEDLINE: Single-Domain Antibodies, COVID-19, Camelids, New World. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 91 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Medical Research Council, NIAID NIH HHS, Agencia Nacional de Promoción de la Investigación, el Desarrollo Tecnológico y la Innovación.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Since the beginning of the COVID-19 pandemic, there has been a significant need to develop antivirals and vaccines to combat the disease. In this work, we developed llama-derived nanobodies (Nbs) directed against the receptor binding domain (RBD) and other domains of the Spike (S) protein of SARS-CoV-2. Most of the Nbs with neutralizing properties were directed to RBD and were able to block S-2P/ACE2 interaction. Three neutralizing Nbs recognized the N-terminal domain (NTD) of the S-2P protein. Intranasal administration of Nbs induced protection ranging from 40% to 80% after challenge with the WA1/2020 strain in k18-hACE2 transgenic mice. Interestingly, protection was associated with a significant reduction in virus replication in nasal turbinates and a reduction in virus load in the brain. Employing pseudovirus neutralization assays, we identified Nbs with neutralizing capacity against the Alpha, Beta, Delta, and Omicron variants, including a Nb capable of neutralizing all variants tested. Furthermore, cocktails of different Nbs performed better than individual Nbs at neutralizing two Omicron variants (B.1.529 and BA.2). Altogether, the data suggest the potential of SARS-CoV-2 specific Nbs for intranasal treatment of COVID-19 encephalitis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Single-Domain AntibodiesCOVID-19Camelids, New WorldAnimalsMiceHumansAngiotensin-Converting Enzyme 2SARS-CoV-2PandemicsBrainMice, TransgenicSpike Glycoprotein, CoronavirusAntibodies, NeutralizingAntibodies, Viral

Stichwörter der Autor:innen

SARS-CoV-2intranasal treatmentnanobodiesvariants of concernvirus neutralization

Substanzen

Angiotensin-Converting Enzyme 2Single-Domain AntibodiesSpike Glycoprotein, CoronavirusAntibodies, NeutralizingAntibodies, Viralspike protein, SARS-CoV-2

Autor:innen und Institutionen

  • Instituto de Química Física de los Materiales, Medio Ambiente y Energía (INQUIMAE), Universidad de Buenos Aires, Consejo Nacional de Investigaciones Científicas y Técnicas, Buenos Aires ZC 1428, Argentina.
  • Incuinta, Instituto Nacional de Tecnología Agropecuaria (INTA), Hurlingham, Buenos Aires ZC 1686, Argentina.
  • Instituto de Virología e Innovaciones Tecnológicas, Consejo Nacional de Investigaciones Científicas y Técnicas (IVIT-CONICET), Hurlingham, Buenos Aires ZC 1686, Argentina.
  • Instituto de Química Biológica de la Facultad de Ciencias Exactas y Naturales (IQUIBICEN), Departamento de Química Biológicas, Consejo Nacional de Investigaciones Científicas y Técnicas, Buenos Aires ZC 1428, Argentina.
  • Centro de Investigaciones en Ciencias Veterinarias y Agronómicas (CICVyA), Instituto Nacional de Tecnología Agropecuaria (INTA), Hurlingham, Buenos Aires ZC 1686, Argentina.
  • Department of Entomology, College of Agriculture and Life Sciences, Fralin Life Science Institute, Virginia Polytechnic Institute and State University, Blacksburg, VA 24061, USA.

ORCID-Profile: Marina Bok, Rafael Betanzos San Juan, Albert Jonathan Auguste, Lijuan Yuan, Lorena Itat Ibañez

Förderung

  • Medical Research Council
  • NIAID NIH HHS
  • Agencia Nacional de Promoción de la Investigación, el Desarrollo Tecnológico y la Innovación
  • National Institute of Allergy and Infectious Diseases
  • Virginia Tech

Zitieren

APA

Pavan, M. F., Bok, M., Betanzos San Juan, R., Malito, J. P., Marcoppido, G. A., Franco, D. R., Militelo, D. A., Schammas, J. M., Bari, S. E., Stone, W., López, K., Porier, D. L., Muller, J. A., Auguste, A. J., Yuan, L., Wigdorovitz, A., Parreño, V. G., & Ibañez, L. I. (2024). SARS-CoV-2 Specific Nanobodies Neutralize Different Variants of Concern and Reduce Virus Load in the Brain of h-ACE2 Transgenic Mice. Viruses. https://doi.org/10.3390/v16020185

Vancouver

Pavan MF, Bok M, Betanzos San Juan R, Malito JP, Marcoppido GA, Franco DR, et al. SARS-CoV-2 Specific Nanobodies Neutralize Different Variants of Concern and Reduce Virus Load in the Brain of h-ACE2 Transgenic Mice. Viruses. 2024. doi:10.3390/v16020185

BibTeX
@article{Pavan2024,
  author = {Pavan, María Florencia and Bok, Marina and Betanzos San Juan, Rafael and Malito, Juan Pablo and Marcoppido, Gisela Ariana and Franco, Diego Rafael and Militelo, Daniela Ayelen and Schammas, Juan Manuel and Bari, Sara Elizabeth and Stone, William and López, Krisangel and Porier, Danielle LaBrie and Muller, John Anthony and Auguste, Albert Jonathan and Yuan, Lijuan and Wigdorovitz, Andrés and Parreño, Viviana Gladys and Ibañez, Lorena Itat},
  title = {SARS-CoV-2 Specific Nanobodies Neutralize Different Variants of Concern and Reduce Virus Load in the Brain of h-ACE2 Transgenic Mice},
  journal = {Viruses},
  year = {2024},
  doi = {10.3390/v16020185}
}
Kostenlos starten →